Global Bumetanide Tablets Market Research Report 2021
SKU ID :QYR-19366822 | Published Date: 14-Oct-2021 | No. of pages: 105Description
TOC
1 Bumetanide Tablets Market Overview
1.1 Product Overview and Scope of Bumetanide Tablets
1.2 Bumetanide Tablets Segment by Type
1.2.1 Global Bumetanide Tablets Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 1mg
1.2.3 5mg
1.3 Bumetanide Tablets Segment by Application
1.3.1 Global Bumetanide Tablets Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Bumetanide Tablets Market Size Estimates and Forecasts
1.4.1 Global Bumetanide Tablets Revenue 2016-2027
1.4.2 Global Bumetanide Tablets Sales 2016-2027
1.4.3 Bumetanide Tablets Market Size by Region: 2016 Versus 2021 Versus 2027
2 Bumetanide Tablets Market Competition by Manufacturers
2.1 Global Bumetanide Tablets Sales Market Share by Manufacturers (2016-2021)
2.2 Global Bumetanide Tablets Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Bumetanide Tablets Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Bumetanide Tablets Manufacturing Sites, Area Served, Product Type
2.5 Bumetanide Tablets Market Competitive Situation and Trends
2.5.1 Bumetanide Tablets Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Bumetanide Tablets Players Market Share by Revenue
2.5.3 Global Bumetanide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bumetanide Tablets Retrospective Market Scenario by Region
3.1 Global Bumetanide Tablets Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Bumetanide Tablets Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Bumetanide Tablets Market Facts & Figures by Country
3.3.1 North America Bumetanide Tablets Sales by Country
3.3.2 North America Bumetanide Tablets Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Bumetanide Tablets Market Facts & Figures by Country
3.4.1 Europe Bumetanide Tablets Sales by Country
3.4.2 Europe Bumetanide Tablets Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Bumetanide Tablets Market Facts & Figures by Region
3.5.1 Asia Pacific Bumetanide Tablets Sales by Region
3.5.2 Asia Pacific Bumetanide Tablets Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Bumetanide Tablets Market Facts & Figures by Country
3.6.1 Latin America Bumetanide Tablets Sales by Country
3.6.2 Latin America Bumetanide Tablets Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Bumetanide Tablets Market Facts & Figures by Country
3.7.1 Middle East and Africa Bumetanide Tablets Sales by Country
3.7.2 Middle East and Africa Bumetanide Tablets Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Bumetanide Tablets Historic Market Analysis by Type
4.1 Global Bumetanide Tablets Sales Market Share by Type (2016-2021)
4.2 Global Bumetanide Tablets Revenue Market Share by Type (2016-2021)
4.3 Global Bumetanide Tablets Price by Type (2016-2021)
5 Global Bumetanide Tablets Historic Market Analysis by Application
5.1 Global Bumetanide Tablets Sales Market Share by Application (2016-2021)
5.2 Global Bumetanide Tablets Revenue Market Share by Application (2016-2021)
5.3 Global Bumetanide Tablets Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Teva
6.1.1 Teva Corporation Information
6.1.2 Teva Description and Business Overview
6.1.3 Teva Bumetanide Tablets Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Teva Bumetanide Tablets Product Portfolio
6.1.5 Teva Recent Developments/Updates
6.2 Zydus Pharmaceuticals
6.2.1 Zydus Pharmaceuticals Corporation Information
6.2.2 Zydus Pharmaceuticals Description and Business Overview
6.2.3 Zydus Pharmaceuticals Bumetanide Tablets Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Zydus Pharmaceuticals Bumetanide Tablets Product Portfolio
6.2.5 Zydus Pharmaceuticals Recent Developments/Updates
6.3 Validus Pharmaceuticals
6.3.1 Validus Pharmaceuticals Corporation Information
6.3.2 Validus Pharmaceuticals Description and Business Overview
6.3.3 Validus Pharmaceuticals Bumetanide Tablets Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Validus Pharmaceuticals Bumetanide Tablets Product Portfolio
6.3.5 Validus Pharmaceuticals Recent Developments/Updates
6.4 Upsher-Smith
6.4.1 Upsher-Smith Corporation Information
6.4.2 Upsher-Smith Description and Business Overview
6.4.3 Upsher-Smith Bumetanide Tablets Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Upsher-Smith Bumetanide Tablets Product Portfolio
6.4.5 Upsher-Smith Recent Developments/Updates
6.5 Amneal
6.5.1 Amneal Corporation Information
6.5.2 Amneal Description and Business Overview
6.5.3 Amneal Bumetanide Tablets Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Amneal Bumetanide Tablets Product Portfolio
6.5.5 Amneal Recent Developments/Updates
6.6 Sandoz
6.6.1 Sandoz Corporation Information
6.6.2 Sandoz Description and Business Overview
6.6.3 Sandoz Bumetanide Tablets Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Sandoz Bumetanide Tablets Product Portfolio
6.6.5 Sandoz Recent Developments/Updates
7 Bumetanide Tablets Manufacturing Cost Analysis
7.1 Bumetanide Tablets Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Bumetanide Tablets
7.4 Bumetanide Tablets Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Bumetanide Tablets Distributors List
8.3 Bumetanide Tablets Customers
9 Bumetanide Tablets Market Dynamics
9.1 Bumetanide Tablets Industry Trends
9.2 Bumetanide Tablets Growth Drivers
9.3 Bumetanide Tablets Market Challenges
9.4 Bumetanide Tablets Market Restraints
10 Global Market Forecast
10.1 Bumetanide Tablets Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Bumetanide Tablets by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Bumetanide Tablets by Type (2022-2027)
10.2 Bumetanide Tablets Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Bumetanide Tablets by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Bumetanide Tablets by Application (2022-2027)
10.3 Bumetanide Tablets Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Bumetanide Tablets by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Bumetanide Tablets by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
Tables & Figures
List of Tables
Table 1. Global Bumetanide Tablets Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Bumetanide Tablets Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Bumetanide Tablets Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Bumetanide Tablets Covered in This Study
Table 5. Global Bumetanide Tablets Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Bumetanide Tablets Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Bumetanide Tablets Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Bumetanide Tablets Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Bumetanide Tablets Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Bumetanide Tablets Manufacturing Sites and Area Served
Table 11. Manufacturers Bumetanide Tablets Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Bumetanide Tablets by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bumetanide Tablets as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Bumetanide Tablets Sales by Region (2016-2021) & (K Units)
Table 16. Global Bumetanide Tablets Sales Market Share by Region (2016-2021)
Table 17. Global Bumetanide Tablets Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Bumetanide Tablets Sales by Country (2016-2021) & (K Units)
Table 19. North America Bumetanide Tablets Sales Market Share by Country (2016-2021)
Table 20. North America Bumetanide Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Bumetanide Tablets Revenue Market Share by Country (2016-2021)
Table 22. Europe Bumetanide Tablets Sales by Country (2016-2021) & (K Units)
Table 23. Europe Bumetanide Tablets Sales Market Share by Country (2016-2021)
Table 24. Europe Bumetanide Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Bumetanide Tablets Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Bumetanide Tablets Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Bumetanide Tablets Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Bumetanide Tablets Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Bumetanide Tablets Revenue Market Share by Region (2016-2021)
Table 30. Latin America Bumetanide Tablets Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Bumetanide Tablets Sales Market Share by Country (2016-2021)
Table 32. Latin America Bumetanide Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Bumetanide Tablets Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Bumetanide Tablets Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Bumetanide Tablets Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Bumetanide Tablets Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Bumetanide Tablets Revenue Market Share by Country (2016-2021)
Table 38. Global Bumetanide Tablets Sales (K Units) by Type (2016-2021)
Table 39. Global Bumetanide Tablets Sales Market Share by Type (2016-2021)
Table 40. Global Bumetanide Tablets Revenue (Million US$) by Type (2016-2021)
Table 41. Global Bumetanide Tablets Revenue Share by Type (2016-2021)
Table 42. Global Bumetanide Tablets Price (USD/Unit) by Type (2016-2021)
Table 43. Global Bumetanide Tablets Sales (K Units) by Application (2016-2021)
Table 44. Global Bumetanide Tablets Sales Market Share by Application (2016-2021)
Table 45. Global Bumetanide Tablets Revenue (Million US$) by Application (2016-2021)
Table 46. Global Bumetanide Tablets Revenue Share by Application (2016-2021)
Table 47. Global Bumetanide Tablets Price (USD/Unit) by Application (2016-2021)
Table 48. Teva Corporation Information
Table 49. Teva Description and Business Overview
Table 50. Teva Bumetanide Tablets Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Teva Bumetanide Tablets Product
Table 52. Teva Recent Developments/Updates
Table 53. Zydus Pharmaceuticals Corporation Information
Table 54. Zydus Pharmaceuticals Description and Business Overview
Table 55. Zydus Pharmaceuticals Bumetanide Tablets Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Zydus Pharmaceuticals Bumetanide Tablets Product
Table 57. Zydus Pharmaceuticals Recent Developments/Updates
Table 58. Validus Pharmaceuticals Corporation Information
Table 59. Validus Pharmaceuticals Description and Business Overview
Table 60. Validus Pharmaceuticals Bumetanide Tablets Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Validus Pharmaceuticals Bumetanide Tablets Product
Table 62. Validus Pharmaceuticals Recent Developments/Updates
Table 63. Upsher-Smith Corporation Information
Table 64. Upsher-Smith Description and Business Overview
Table 65. Upsher-Smith Bumetanide Tablets Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Upsher-Smith Bumetanide Tablets Product
Table 67. Upsher-Smith Recent Developments/Updates
Table 68. Amneal Corporation Information
Table 69. Amneal Description and Business Overview
Table 70. Amneal Bumetanide Tablets Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. Amneal Bumetanide Tablets Product
Table 72. Amneal Recent Developments/Updates
Table 73. Sandoz Corporation Information
Table 74. Sandoz Description and Business Overview
Table 75. Sandoz Bumetanide Tablets Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Sandoz Bumetanide Tablets Product
Table 77. Sandoz Recent Developments/Updates
Table 78. Production Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Bumetanide Tablets Distributors List
Table 81. Bumetanide Tablets Customers List
Table 82. Bumetanide Tablets Market Trends
Table 83. Bumetanide Tablets Growth Drivers
Table 84. Bumetanide Tablets Market Challenges
Table 85. Bumetanide Tablets Market Restraints
Table 86. Global Bumetanide Tablets Sales Forecast by Type (2022-2027) & (K Units)
Table 87. Global Bumetanide Tablets Sales Market Share Forecast by Type (2022-2027)
Table 88. Global Bumetanide Tablets Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 89. Global Bumetanide Tablets Revenue Market Share Forecast by Type (2022-2027)
Table 90. Global Bumetanide Tablets Sales Forecast by Application (2022-2027) & (K Units)
Table 91. Global Bumetanide Tablets Sales Market Share Forecast by Application (2022-2027)
Table 92. Global Bumetanide Tablets Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 93. Global Bumetanide Tablets Revenue Market Share Forecast by Application (2022-2027)
Table 94. Global Bumetanide Tablets Sales Forecast by Region (2022-2027) & (K Units)
Table 95. Global Bumetanide Tablets Sales Market Share Forecast by Region (2022-2027)
Table 96. Global Bumetanide Tablets Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 97. Global Bumetanide Tablets Revenue Market Share Forecast by Region (2022-2027)
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Bumetanide Tablets
Figure 2. Global Bumetanide Tablets Market Share by Type in 2020 & 2027
Figure 3. 1mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. Global Bumetanide Tablets Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Drug Store
Figure 8. Global Bumetanide Tablets Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Bumetanide Tablets Market Size 2016-2027 (US$ Million)
Figure 10. Global Bumetanide Tablets Sales 2016-2027 (K Units)
Figure 11. Global Bumetanide Tablets Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Bumetanide Tablets Sales Share by Manufacturers in 2020
Figure 13. Global Bumetanide Tablets Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Bumetanide Tablets Players: Market Share by Revenue in 2020
Figure 15. Bumetanide Tablets Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Bumetanide Tablets Sales Market Share by Region (2016-2021)
Figure 17. Global Bumetanide Tablets Sales Market Share by Region in 2020
Figure 18. Global Bumetanide Tablets Revenue Market Share by Region (2016-2021)
Figure 19. Global Bumetanide Tablets Revenue Market Share by Region in 2020
Figure 20. U.S. Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. U.A.E Bumetanide Tablets Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Bumetanide Tablets by Type (2016-2021)
Figure 45. Sales Market Share of Bumetanide Tablets by Application (2016-2021)
Figure 46. Sales Market Share of Bumetanide Tablets by Application in 2020
Figure 47. Revenue Share of Bumetanide Tablets by Application (2016-2021)
Figure 48. Revenue Share of Bumetanide Tablets by Application in 2020
Figure 49. Manufacturing Cost Structure of Bumetanide Tablets
Figure 50. Manufacturing Process Analysis of Bumetanide Tablets
Figure 51. Bumetanide Tablets Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Companies
Teva
Zydus Pharmaceuticals
Validus Pharmaceuticals
Upsher-Smith
Amneal
Sandoz
- PRICE
-
$2900$5800$4350Buy Now